These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31883127)

  • 1. Quality of life, treatment satisfaction, and adherence to treatment in patients with vesicular hand eczema: A cross-sectional study.
    Politiek K; Ofenloch RF; Angelino MJ; van den Hoed E; Schuttelaar MLA
    Contact Dermatitis; 2020 Apr; 82(4):201-210. PubMed ID: 31883127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on quality of life of alitretinoin in severe chronic hand eczema: FUGETTA real-world study.
    Augustin M; Thaçi D; Kamps A
    J Dtsch Dermatol Ges; 2016 Dec; 14(12):1261-1270. PubMed ID: 27992140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Quality of Life in Hand Eczema Questionnaire (QOLHEQ): validation of the German version of a new disease-specific measure of quality of life for patients with hand eczema.
    Ofenloch RF; Weisshaar E; Dumke AK; Molin S; Diepgen TL; Apfelbacher C
    Br J Dermatol; 2014 Aug; 171(2):304-12. PubMed ID: 24397866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment.
    Oosterhaven JAF; Schuttelaar MLA
    BMJ Open; 2018 Jul; 8(7):e020192. PubMed ID: 29997136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New evidence for construct validity and interpretability of the German Quality of Life in Hand Eczema Questionnaire (QOLHEQ).
    Ofenloch RF; Weisshaar E; Apfelbacher C
    Contact Dermatitis; 2020 Sep; 83(3):189-195. PubMed ID: 32419133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids.
    Cortesi PA; Scalone L; Belisari A; Bonamonte D; Cannavò SP; Cristaudo A; De Pità O; Gallo R; Giannetti A; Gola M; Pigatto PD; Mantovani LG
    Contact Dermatitis; 2014 Mar; 70(3):158-68. PubMed ID: 24102212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hand eczema: A prevalent disease in the general population associated with reduced quality of life and poor overall health measures.
    Quaade AS; Alinaghi F; Dietz JB; Erichsen CY; Johansen JD
    Contact Dermatitis; 2023 Dec; 89(6):453-463. PubMed ID: 37634937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Life in Hand Eczema Questionnaire: Validation of the Japanese version of a disease-specific measure of quality of life for hand eczema patients.
    Minamoto K; Diepgen TL; Sato K; Noguchi H; Yamashita N; Yoshimura K; Ofenloch RF
    J Dermatol; 2018 Nov; 45(11):1301-1305. PubMed ID: 30264908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alitretinoin on quality of life of patients having chronic hand eczema: an observational study.
    Gola M; D'Erme AM; Milanesi N; Marmugi L
    Dermatitis; 2013; 24(4):166-9. PubMed ID: 23857016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hand eczema in Germany: 5-year follow-up data from the CARPE registry.
    Apfelbacher CJ; Ofenloch RF; Weisshaar E; Molin S; Bauer A; Mahler V; Heinrich A; von Kiedrowski R; Schmitt J; Elsner P; Diepgen TL
    Contact Dermatitis; 2019 Jan; 80(1):45-53. PubMed ID: 30246346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life, use of topical medications and socio-economic data in hand eczema: a Swedish nationwide survey.
    Bingefors K; Lindberg M; Isacson D
    Acta Derm Venereol; 2011 Jun; 91(4):452-8. PubMed ID: 21547337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Chronic Hand Eczema.
    de León FJ; Berbegal L; Silvestre JF
    Actas Dermosifiliogr; 2015 Sep; 106(7):533-44. PubMed ID: 26005193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Dutch Quality of Life in Hand Eczema Questionnaire (QOLHEQ).
    Oosterhaven JAF; Ofenloch RF; Schuttelaar MLA
    Br J Dermatol; 2020 Jul; 183(1):86-95. PubMed ID: 31560803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive change in hand care habits using therapeutic patient education in chronic hand eczema.
    Tauber M; Lourari S; Bérard E; Questel E; Redoules D; Giordano-Labadie F; Simon M; Carle P;
    Contact Dermatitis; 2020 Jan; 82(1):10-17. PubMed ID: 31461531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azathioprine treatment and drug survival in patients with chronic hand eczema - results from daily practice.
    Oosterhaven JA; Politiek K; Schuttelaar MA
    Contact Dermatitis; 2017 May; 76(5):304-307. PubMed ID: 28386975
    [No Abstract]   [Full Text] [Related]  

  • 16. What's new in the treatment of eczemas.
    Gola M; Carpentieri A; Loconsole F
    G Ital Dermatol Venereol; 2017 Dec; 152(6):560-564. PubMed ID: 29050445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alitretinoin for the treatment of severe chronic hand eczema.
    Paulden M; Rodgers M; Griffin S; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
    Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Life and Its Association With Treatment Satisfaction, Adherence to Medication, and Trust in Physician Among Patients With Hypertension: A Cross-Sectional Designed Study.
    Jneid S; Jabbour H; Hajj A; Sarkis A; Licha H; Hallit S; Khabbaz LR
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):532-542. PubMed ID: 29916266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hand eczema with topical anti-inflammatory drugs other than topical corticosteroids.
    Saeki H; Kanda N
    Med; 2024 Oct; 5(10):1203-1205. PubMed ID: 39395404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of medication adherence and treatment satisfaction in Japanese patients with psoriasis of various severities.
    Ichiyama S; Ito M; Funasaka Y; Abe M; Nishida E; Muramatsu S; Nishihara H; Kato H; Morita A; Imafuku S; Saeki H
    J Dermatol; 2018 Jun; 45(6):727-731. PubMed ID: 29356075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.